Amphastar Receives FDA Approval for Ganirelix Acetate Injection
Go back to Amphastar Receives FDA Approval for Ganirelix Acetate Injection| AMER PHYSICIANS (NASDAQ: AMPH) | Delayed: 25.61 +0.47 (1.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.14 | 52 Week High | $21.53 | |||
| Open | $25.27 | 52 Week Low | $10.50 | |||
| Day High | $25.65 | P/E | 7.83 | |||
| Day Low | $25.22 | EPS | $3.27 | |||
| Volume | 29,996 | |||||



